To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5629 | Zinc17167211 |
Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)
More description
|
|
| DCC5628 | Zinc17043486 |
Novel CDK6 inhibitor
More description
|
|
| DCC5627 | Zinc12909780 |
Novel dose-dependent inhibitor of TNF-α-induced NF-κB activation
More description
|
|
| DCC5626 | Zinc09410451 |
Potent Ebolavirus (EBOV) Inhibitor
More description
|
|
| DCC5625 | Zinc08985213 |
Novel effective immune check point inhibitor (ICI) against the suppression of T-cell activation, proliferation, and tumor cell eradication.
More description
|
|
| DCC5624 | Zinc08792355 |
Novel SIRT1 inhibitor
More description
|
|
| DCC5623 | Zinc08792229 |
Novel SIRT1 inhibitor
More description
|
|
| DCC5622 | Zinc08790006 |
Novel SIRT1 inhibitor
More description
|
|
| DCC5621 | Zinc08438472 |
Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)
More description
|
|
| DCC5620 | Zinc06472206 |
Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)
More description
|
|
| DCC5619 | Zinc05848961 |
Novel TNF-α inhibitor
More description
|
|
| DCC5618 | Zinc04574788 |
Novel potent small molecule lligand of miR-21, binding to the major groove of miR-21 hairpin conformation
More description
|
|
| DCC5617 | Zinc04515726 |
Novel effective immune checkpoint inhibitor (ICI) against the suppression of T-cell activation, proliferation, and tumor cell eradication.
More description
|
|
| DCC5616 | Zinc04502991 |
Novel TNF-α inhibitor
More description
|
|
| DCC5615 | Zinc04177596 |
Novel Nef Protein Inhibitor; Anti-HIV
More description
|
|
| DCC5614 | Zinc04085549 |
Novel blocker of AKT1-FAK interaction, reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylation
More description
|
|
| DCC5613 | Zinc03838680 |
Potent VEGFR-2 inhibitor
More description
|
|
| DCC5612 | Zinc01765622 |
Novel antagonist for mLST8
More description
|
|
| DCC5611 | Zinc00723145 |
The first nonpeptidic inhibitor of ovarian cancer cells growth targeting human thymidylate synthase (hTS)
More description
|
|
| DCC5610 | Zilpaterol |
Growth promotant, acting as a ß-AR (ß-Adrenergic) agonist
More description
|
|
| DCC5609 | Ziconotide |
Atypical analgesic agent for the amelioration of severe and chronic pain
More description
|
|
| DCC5608 | Z-ggr-amc |
Fluorogenic peptide substrate for a direct fluorometric assay of urokinase, tissue-type plasminogen activator, trypsin and thrombin
More description
|
|
| DCC5607 | Zg-2033 |
Novel Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist
More description
|
|
| DCC5606 | Zfh7116 |
Novel inhibitor of pro-HGF activation
More description
|
|
| DCC5605 | Zdwx-25 |
Novel daul inhibitor of GSK-3β (IC 50 = 71 nM) and DYRK1A (IC 50 = 103 nM) with good blood-brain barrier penetrability, inhibiting hyperphosphorylation of tau protein in okadaic acid (OKA)-induced SH-SY5Y cells
More description
|
|
| DCC5604 | Z-don-val-pro-leu-ome |
Site specific inhibitor of tissue transglutaminase
More description
|
|
| DCC5603 | Zdlt-1 |
Novel potent HDAC inhibitor with IC50 values for class I HDACs 1, 2, and 3 below 4 nM, and IC50 for HDAC6 at 6 nM.
More description
|
|
| DCC5602 | Zdhhc Substrate Peptide |
ZDHHC (zinc finger Asp-His-His-Cys) substrate peptide, a 15-mer peptide sequence from KRas4a plus two tryptophan residues
More description
|
|
| DCC5601 | zd6169 |
Potassium channel opener
More description
|
|
| DCC5600 | Zd6126 |
Vascular targeting agent (VTA)
More description
|
|